Home
>
National Drug Code (NDC)
>
Bupropion Hydrochloride
Bupropion Hydrochloride - 51079-109-03 - (bupropion hydrochloride)
Drug Information of Bupropion Hydrochloride
| Product NDC: | 51079-109 |
| Proprietary Name: | Bupropion Hydrochloride |
| Non Proprietary Name: | bupropion hydrochloride |
| Active Ingredient(s): | 300 mg/1 & nbsp; bupropion hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Bupropion Hydrochloride
| Product NDC: | 51079-109 |
| Labeler Name: | Mylan Institutional Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090942 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121211 |
Package Information of Bupropion Hydrochloride
| Package NDC: | 51079-109-03 |
| Package Description: | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-109-03) > 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (51079-109-01) |
NDC Information of Bupropion Hydrochloride
| NDC Code | 51079-109-03 |
| Proprietary Name | Bupropion Hydrochloride |
| Package Description | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-109-03) > 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (51079-109-01) |
| Product NDC | 51079-109 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | bupropion hydrochloride |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20121211 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Institutional Inc. |
| Substance Name | BUPROPION HYDROCHLORIDE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |
